GO:0006520 | cellular amino acid metabolic process | 16.67% (19/114) | 4.64 | 0.0 | 0.0 |
GO:0006082 | organic acid metabolic process | 17.54% (20/114) | 4.26 | 0.0 | 0.0 |
GO:0019752 | carboxylic acid metabolic process | 17.54% (20/114) | 4.27 | 0.0 | 0.0 |
GO:0043436 | oxoacid metabolic process | 17.54% (20/114) | 4.27 | 0.0 | 0.0 |
GO:0044281 | small molecule metabolic process | 20.18% (23/114) | 3.55 | 0.0 | 0.0 |
GO:0043039 | tRNA aminoacylation | 10.53% (12/114) | 5.43 | 0.0 | 0.0 |
GO:0043038 | amino acid activation | 10.53% (12/114) | 5.43 | 0.0 | 0.0 |
GO:0004812 | aminoacyl-tRNA ligase activity | 10.53% (12/114) | 5.39 | 0.0 | 0.0 |
GO:0016875 | ligase activity, forming carbon-oxygen bonds | 10.53% (12/114) | 5.39 | 0.0 | 0.0 |
GO:0016874 | ligase activity | 12.28% (14/114) | 4.65 | 0.0 | 0.0 |
GO:0006418 | tRNA aminoacylation for protein translation | 9.65% (11/114) | 5.44 | 0.0 | 0.0 |
GO:0140101 | catalytic activity, acting on a tRNA | 10.53% (12/114) | 4.96 | 0.0 | 0.0 |
GO:0006399 | tRNA metabolic process | 10.53% (12/114) | 4.76 | 0.0 | 0.0 |
GO:0034660 | ncRNA metabolic process | 10.53% (12/114) | 4.39 | 0.0 | 0.0 |
GO:0140098 | catalytic activity, acting on RNA | 11.4% (13/114) | 4.13 | 0.0 | 0.0 |
GO:1901564 | organonitrogen compound metabolic process | 19.3% (22/114) | 2.11 | 0.0 | 0.0 |
GO:0006725 | cellular aromatic compound metabolic process | 19.3% (22/114) | 2.09 | 0.0 | 0.0 |
GO:0044283 | small molecule biosynthetic process | 7.02% (8/114) | 4.23 | 0.0 | 0.0 |
GO:1901360 | organic cyclic compound metabolic process | 19.3% (22/114) | 2.07 | 0.0 | 0.0 |
GO:0046483 | heterocycle metabolic process | 18.42% (21/114) | 2.05 | 0.0 | 0.0 |
GO:0044237 | cellular metabolic process | 26.32% (30/114) | 1.59 | 0.0 | 0.0 |
GO:0008144 | drug binding | 16.67% (19/114) | 2.19 | 0.0 | 0.0 |
GO:0008652 | cellular amino acid biosynthetic process | 5.26% (6/114) | 4.93 | 0.0 | 0.0 |
GO:0034641 | cellular nitrogen compound metabolic process | 19.3% (22/114) | 1.89 | 0.0 | 1e-06 |
GO:0046394 | carboxylic acid biosynthetic process | 5.26% (6/114) | 4.66 | 0.0 | 1e-06 |
GO:0016053 | organic acid biosynthetic process | 5.26% (6/114) | 4.66 | 0.0 | 1e-06 |
GO:0003824 | catalytic activity | 37.72% (43/114) | 1.1 | 0.0 | 3e-06 |
GO:0036094 | small molecule binding | 20.18% (23/114) | 1.72 | 0.0 | 3e-06 |
GO:1901607 | alpha-amino acid biosynthetic process | 4.39% (5/114) | 4.86 | 1e-06 | 6e-06 |
GO:0005524 | ATP binding | 14.04% (16/114) | 2.14 | 1e-06 | 6e-06 |
GO:0043168 | anion binding | 19.3% (22/114) | 1.7 | 1e-06 | 7e-06 |
GO:0030554 | adenyl nucleotide binding | 14.04% (16/114) | 2.1 | 1e-06 | 7e-06 |
GO:0032559 | adenyl ribonucleotide binding | 14.04% (16/114) | 2.1 | 1e-06 | 7e-06 |
GO:1901605 | alpha-amino acid metabolic process | 5.26% (6/114) | 4.06 | 1e-06 | 1.1e-05 |
GO:0016070 | RNA metabolic process | 13.16% (15/114) | 2.12 | 2e-06 | 1.3e-05 |
GO:0006807 | nitrogen compound metabolic process | 21.93% (25/114) | 1.46 | 3e-06 | 2e-05 |
GO:0009987 | cellular process | 32.46% (37/114) | 1.07 | 4e-06 | 3e-05 |
GO:0006139 | nucleobase-containing compound metabolic process | 14.91% (17/114) | 1.84 | 4e-06 | 3.2e-05 |
GO:0035639 | purine ribonucleoside triphosphate binding | 14.04% (16/114) | 1.91 | 5e-06 | 3.2e-05 |
GO:0097159 | organic cyclic compound binding | 26.32% (30/114) | 1.24 | 5e-06 | 3.3e-05 |
GO:1901363 | heterocyclic compound binding | 26.32% (30/114) | 1.24 | 5e-06 | 3.3e-05 |
GO:0032555 | purine ribonucleotide binding | 14.04% (16/114) | 1.88 | 6e-06 | 4e-05 |
GO:0017076 | purine nucleotide binding | 14.04% (16/114) | 1.87 | 7e-06 | 4.3e-05 |
GO:0008152 | metabolic process | 33.33% (38/114) | 1.02 | 8e-06 | 4.6e-05 |
GO:0032553 | ribonucleotide binding | 14.04% (16/114) | 1.81 | 1.2e-05 | 7e-05 |
GO:0090304 | nucleic acid metabolic process | 13.16% (15/114) | 1.89 | 1.2e-05 | 7.2e-05 |
GO:0003674 | molecular_function | 52.63% (60/114) | 0.66 | 1.4e-05 | 8e-05 |
GO:0097367 | carbohydrate derivative binding | 14.04% (16/114) | 1.79 | 1.4e-05 | 8e-05 |
GO:1901566 | organonitrogen compound biosynthetic process | 7.89% (9/114) | 2.62 | 1.6e-05 | 8.7e-05 |
GO:0008080 | N-acetyltransferase activity | 4.39% (5/114) | 3.83 | 2.5e-05 | 0.000136 |
GO:0016410 | N-acyltransferase activity | 4.39% (5/114) | 3.8 | 2.8e-05 | 0.00015 |
GO:0071704 | organic substance metabolic process | 23.68% (27/114) | 1.17 | 3.8e-05 | 0.000196 |
GO:0009072 | aromatic amino acid family metabolic process | 3.51% (4/114) | 4.35 | 4e-05 | 0.000203 |
GO:0016746 | transferase activity, transferring acyl groups | 6.14% (7/114) | 2.91 | 4.1e-05 | 0.000204 |
GO:0009073 | aromatic amino acid family biosynthetic process | 2.63% (3/114) | 5.35 | 4.3e-05 | 0.000213 |
GO:0009123 | nucleoside monophosphate metabolic process | 1.75% (2/114) | 6.93 | 6.6e-05 | 0.000272 |
GO:0009167 | purine ribonucleoside monophosphate metabolic process | 1.75% (2/114) | 6.93 | 6.6e-05 | 0.000272 |
GO:0009161 | ribonucleoside monophosphate metabolic process | 1.75% (2/114) | 6.93 | 6.6e-05 | 0.000272 |
GO:0009124 | nucleoside monophosphate biosynthetic process | 1.75% (2/114) | 6.93 | 6.6e-05 | 0.000272 |
GO:0009126 | purine nucleoside monophosphate metabolic process | 1.75% (2/114) | 6.93 | 6.6e-05 | 0.000272 |
GO:0009127 | purine nucleoside monophosphate biosynthetic process | 1.75% (2/114) | 6.93 | 6.6e-05 | 0.000272 |
GO:0009168 | purine ribonucleoside monophosphate biosynthetic process | 1.75% (2/114) | 6.93 | 6.6e-05 | 0.000272 |
GO:0009156 | ribonucleoside monophosphate biosynthetic process | 1.75% (2/114) | 6.93 | 6.6e-05 | 0.000272 |
GO:0016407 | acetyltransferase activity | 4.39% (5/114) | 3.58 | 5.8e-05 | 0.000282 |
GO:0000166 | nucleotide binding | 15.79% (18/114) | 1.49 | 6.6e-05 | 0.000307 |
GO:1901265 | nucleoside phosphate binding | 15.79% (18/114) | 1.49 | 6.6e-05 | 0.000307 |
GO:0019842 | vitamin binding | 4.39% (5/114) | 3.17 | 0.000231 | 0.000936 |
GO:0044238 | primary metabolic process | 21.05% (24/114) | 1.1 | 0.000235 | 0.000938 |
GO:0043167 | ion binding | 22.81% (26/114) | 1.02 | 0.000303 | 0.001189 |
GO:0008150 | biological_process | 39.47% (45/114) | 0.66 | 0.000426 | 0.001651 |
GO:0016740 | transferase activity | 11.4% (13/114) | 1.53 | 0.000568 | 0.002167 |
GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor | 1.75% (2/114) | 5.61 | 0.000652 | 0.002455 |
GO:0009058 | biosynthetic process | 12.28% (14/114) | 1.38 | 0.000926 | 0.003439 |
GO:0016747 | transferase activity, transferring acyl groups other than amino-acyl groups | 4.39% (5/114) | 2.72 | 0.000982 | 0.003455 |
GO:0000105 | histidine biosynthetic process | 1.75% (2/114) | 5.35 | 0.000973 | 0.00347 |
GO:0052803 | imidazole-containing compound metabolic process | 1.75% (2/114) | 5.35 | 0.000973 | 0.00347 |
GO:0006547 | histidine metabolic process | 1.75% (2/114) | 5.35 | 0.000973 | 0.00347 |
GO:0030976 | thiamine pyrophosphate binding | 1.75% (2/114) | 4.93 | 0.001797 | 0.006243 |
GO:0005488 | binding | 28.07% (32/114) | 0.73 | 0.001985 | 0.006808 |
GO:1901681 | sulfur compound binding | 1.75% (2/114) | 4.47 | 0.003474 | 0.011767 |
GO:0043170 | macromolecule metabolic process | 14.04% (16/114) | 1.07 | 0.003677 | 0.012303 |
GO:0016779 | nucleotidyltransferase activity | 2.63% (3/114) | 3.23 | 0.003928 | 0.012981 |
GO:0009260 | ribonucleotide biosynthetic process | 1.75% (2/114) | 3.85 | 0.008319 | 0.019105 |
GO:0046390 | ribose phosphate biosynthetic process | 1.75% (2/114) | 3.85 | 0.008319 | 0.019105 |
GO:0009152 | purine ribonucleotide biosynthetic process | 1.75% (2/114) | 3.85 | 0.008319 | 0.019105 |
GO:0003922 | GMP synthase (glutamine-hydrolyzing) activity | 0.88% (1/114) | 6.93 | 0.008177 | 0.019269 |
GO:0006188 | IMP biosynthetic process | 0.88% (1/114) | 6.93 | 0.008177 | 0.019269 |
GO:0046037 | GMP metabolic process | 0.88% (1/114) | 6.93 | 0.008177 | 0.019269 |
GO:0006432 | phenylalanyl-tRNA aminoacylation | 0.88% (1/114) | 6.93 | 0.008177 | 0.019269 |
GO:0004827 | proline-tRNA ligase activity | 0.88% (1/114) | 6.93 | 0.008177 | 0.019269 |
GO:0004484 | mRNA guanylyltransferase activity | 0.88% (1/114) | 6.93 | 0.008177 | 0.019269 |
GO:0006433 | prolyl-tRNA aminoacylation | 0.88% (1/114) | 6.93 | 0.008177 | 0.019269 |
GO:0006370 | 7-methylguanosine mRNA capping | 0.88% (1/114) | 6.93 | 0.008177 | 0.019269 |
GO:0006177 | GMP biosynthetic process | 0.88% (1/114) | 6.93 | 0.008177 | 0.019269 |
GO:0006189 | 'de novo' IMP biosynthetic process | 0.88% (1/114) | 6.93 | 0.008177 | 0.019269 |
GO:0004486 | methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity | 0.88% (1/114) | 6.93 | 0.008177 | 0.019269 |
GO:0004488 | methylenetetrahydrofolate dehydrogenase (NADP+) activity | 0.88% (1/114) | 6.93 | 0.008177 | 0.019269 |
GO:0004425 | indole-3-glycerol-phosphate synthase activity | 0.88% (1/114) | 6.93 | 0.008177 | 0.019269 |
GO:0004813 | alanine-tRNA ligase activity | 0.88% (1/114) | 6.93 | 0.008177 | 0.019269 |
GO:0006419 | alanyl-tRNA aminoacylation | 0.88% (1/114) | 6.93 | 0.008177 | 0.019269 |
GO:0004814 | arginine-tRNA ligase activity | 0.88% (1/114) | 6.93 | 0.008177 | 0.019269 |
GO:0004358 | glutamate N-acetyltransferase activity | 0.88% (1/114) | 6.93 | 0.008177 | 0.019269 |
GO:0004417 | hydroxyethylthiazole kinase activity | 0.88% (1/114) | 6.93 | 0.008177 | 0.019269 |
GO:0006420 | arginyl-tRNA aminoacylation | 0.88% (1/114) | 6.93 | 0.008177 | 0.019269 |
GO:0046040 | IMP metabolic process | 0.88% (1/114) | 6.93 | 0.008177 | 0.019269 |
GO:0004635 | phosphoribosyl-AMP cyclohydrolase activity | 0.88% (1/114) | 6.93 | 0.008177 | 0.019269 |
GO:0004640 | phosphoribosylanthranilate isomerase activity | 0.88% (1/114) | 6.93 | 0.008177 | 0.019269 |
GO:1901070 | guanosine-containing compound biosynthetic process | 0.88% (1/114) | 6.93 | 0.008177 | 0.019269 |
GO:0003852 | 2-isopropylmalate synthase activity | 0.88% (1/114) | 6.93 | 0.008177 | 0.019269 |
GO:0042724 | thiamine-containing compound biosynthetic process | 0.88% (1/114) | 6.93 | 0.008177 | 0.019269 |
GO:0009098 | leucine biosynthetic process | 0.88% (1/114) | 6.93 | 0.008177 | 0.019269 |
GO:0042723 | thiamine-containing compound metabolic process | 0.88% (1/114) | 6.93 | 0.008177 | 0.019269 |
GO:0009228 | thiamine biosynthetic process | 0.88% (1/114) | 6.93 | 0.008177 | 0.019269 |
GO:0003849 | 3-deoxy-7-phosphoheptulonate synthase activity | 0.88% (1/114) | 6.93 | 0.008177 | 0.019269 |
GO:0006772 | thiamine metabolic process | 0.88% (1/114) | 6.93 | 0.008177 | 0.019269 |
GO:0006551 | leucine metabolic process | 0.88% (1/114) | 6.93 | 0.008177 | 0.019269 |
GO:0003723 | RNA binding | 3.51% (4/114) | 2.32 | 0.008497 | 0.01935 |
GO:0048037 | cofactor binding | 8.77% (10/114) | 1.27 | 0.008594 | 0.019409 |
GO:0006164 | purine nucleotide biosynthetic process | 1.75% (2/114) | 3.69 | 0.010349 | 0.023179 |
GO:0044249 | cellular biosynthetic process | 9.65% (11/114) | 1.23 | 0.007204 | 0.023521 |
GO:1901576 | organic substance biosynthetic process | 9.65% (11/114) | 1.22 | 0.007763 | 0.025046 |
GO:0016879 | ligase activity, forming carbon-nitrogen bonds | 1.75% (2/114) | 3.54 | 0.012575 | 0.027263 |
GO:0072522 | purine-containing compound biosynthetic process | 1.75% (2/114) | 3.54 | 0.012575 | 0.027263 |
GO:0030170 | pyridoxal phosphate binding | 2.63% (3/114) | 2.64 | 0.012418 | 0.027361 |
GO:0070279 | vitamin B6 binding | 2.63% (3/114) | 2.64 | 0.012418 | 0.027361 |
GO:0006397 | mRNA processing | 1.75% (2/114) | 3.47 | 0.01376 | 0.029594 |
GO:0042451 | purine nucleoside biosynthetic process | 0.88% (1/114) | 5.93 | 0.016287 | 0.031304 |
GO:0046129 | purine ribonucleoside biosynthetic process | 0.88% (1/114) | 5.93 | 0.016287 | 0.031304 |
GO:1901068 | guanosine-containing compound metabolic process | 0.88% (1/114) | 5.93 | 0.016287 | 0.031304 |
GO:0004826 | phenylalanine-tRNA ligase activity | 0.88% (1/114) | 5.93 | 0.016287 | 0.031304 |
GO:0004399 | histidinol dehydrogenase activity | 0.88% (1/114) | 5.93 | 0.016287 | 0.031304 |
GO:0019238 | cyclohydrolase activity | 0.88% (1/114) | 5.93 | 0.016287 | 0.031304 |
GO:0008192 | RNA guanylyltransferase activity | 0.88% (1/114) | 5.93 | 0.016287 | 0.031304 |
GO:0009452 | 7-methylguanosine RNA capping | 0.88% (1/114) | 5.93 | 0.016287 | 0.031304 |
GO:0036260 | RNA capping | 0.88% (1/114) | 5.93 | 0.016287 | 0.031304 |
GO:0009082 | branched-chain amino acid biosynthetic process | 0.88% (1/114) | 5.93 | 0.016287 | 0.031304 |
GO:0070568 | guanylyltransferase activity | 0.88% (1/114) | 5.93 | 0.016287 | 0.031304 |
GO:0009081 | branched-chain amino acid metabolic process | 0.88% (1/114) | 5.93 | 0.016287 | 0.031304 |
GO:0005664 | nuclear origin of replication recognition complex | 0.88% (1/114) | 5.93 | 0.016287 | 0.031304 |
GO:0000287 | magnesium ion binding | 1.75% (2/114) | 3.41 | 0.01499 | 0.031987 |
GO:0050662 | coenzyme binding | 6.14% (7/114) | 1.42 | 0.015768 | 0.033384 |
GO:0016071 | mRNA metabolic process | 1.75% (2/114) | 3.29 | 0.017588 | 0.033565 |
GO:0016831 | carboxy-lyase activity | 1.75% (2/114) | 3.23 | 0.018953 | 0.035917 |
GO:0019693 | ribose phosphate metabolic process | 1.75% (2/114) | 3.18 | 0.020361 | 0.037793 |
GO:0009259 | ribonucleotide metabolic process | 1.75% (2/114) | 3.18 | 0.020361 | 0.037793 |
GO:0009150 | purine ribonucleotide metabolic process | 1.75% (2/114) | 3.18 | 0.020361 | 0.037793 |
GO:1901293 | nucleoside phosphate biosynthetic process | 1.75% (2/114) | 3.13 | 0.021812 | 0.039939 |
GO:0009165 | nucleotide biosynthetic process | 1.75% (2/114) | 3.13 | 0.021812 | 0.039939 |
GO:0006529 | asparagine biosynthetic process | 0.88% (1/114) | 5.35 | 0.024332 | 0.040956 |
GO:0000049 | tRNA binding | 0.88% (1/114) | 5.35 | 0.024332 | 0.040956 |
GO:0006528 | asparagine metabolic process | 0.88% (1/114) | 5.35 | 0.024332 | 0.040956 |
GO:0046128 | purine ribonucleoside metabolic process | 0.88% (1/114) | 5.35 | 0.024332 | 0.040956 |
GO:0004066 | asparagine synthase (glutamine-hydrolyzing) activity | 0.88% (1/114) | 5.35 | 0.024332 | 0.040956 |
GO:1901659 | glycosyl compound biosynthetic process | 0.88% (1/114) | 5.35 | 0.024332 | 0.040956 |
GO:0009163 | nucleoside biosynthetic process | 0.88% (1/114) | 5.35 | 0.024332 | 0.040956 |
GO:0042455 | ribonucleoside biosynthetic process | 0.88% (1/114) | 5.35 | 0.024332 | 0.040956 |
GO:0006526 | arginine biosynthetic process | 0.88% (1/114) | 5.35 | 0.024332 | 0.040956 |
GO:0006525 | arginine metabolic process | 0.88% (1/114) | 5.35 | 0.024332 | 0.040956 |
GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines | 0.88% (1/114) | 5.35 | 0.024332 | 0.040956 |
GO:0042278 | purine nucleoside metabolic process | 0.88% (1/114) | 5.35 | 0.024332 | 0.040956 |
GO:0006163 | purine nucleotide metabolic process | 1.75% (2/114) | 3.08 | 0.023304 | 0.042385 |
GO:0019438 | aromatic compound biosynthetic process | 6.14% (7/114) | 1.28 | 0.025438 | 0.042553 |
GO:0072521 | purine-containing compound metabolic process | 1.75% (2/114) | 2.98 | 0.02641 | 0.043909 |
GO:0005737 | cytoplasm | 1.75% (2/114) | 2.89 | 0.029674 | 0.049034 |